TickerFacts.

Verastem, Inc. (VSTM): Revenue

Annual figures by period end, from SEC filings.

$30.91M
Year ended 2025-12-31
$87.53M
Trailing 12 months to 2026-06-30
+128.4%
3-year compound annual growth
-19.0%
5-year compound annual growth
$88.52M2018-12-31: $26.72M2019-12-31: $17.46M2020-12-31: $88.52M2021-12-31: $2.05M2022-12-31: $2.60M2024-12-31: $10.00M2025-12-31: $30.91M$30.91M
2018-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$30.91M+209.1%2026-03-04, From 2025-01-01
2024-12-31$10.00Mn/a2026-03-04, From 2024-01-01
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31$2.60M+26.4%2025-03-20, From 2022-01-01
2021-12-31$2.05M-97.7%2024-03-14, From 2021-01-01
2020-12-31$88.52M+407.1%2023-03-14, From 2020-01-01
2019-12-31$17.46M-34.7%2022-03-28, From 2019-01-01
2018-12-31$26.72Mn/a2021-03-18, From 2018-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Verastem, Inc. (VSTM)2025-12-31$30.91M+209.1%
Foghorn Therapeutics Inc. (FHTX)2025-12-31$30.91M+36.8%
Zomedica Corp. (ZOMDF)2025-12-31$32.03M+17.4%
Bioharvest Sciences Inc. (BHST)2025-12-31$34.51M+37.0%
Cue Biopharma, Inc. (CUE)2025-12-31$27.47M+195.7%
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31$35.58M+370.2%
Earth Science Tech, Inc. (ETST)2026-03-31$35.70M+7.8%
Celularity Inc (CELU)2025-12-31$26.55M-51.0%
Sunshine Biopharma Inc. (SBFM)2025-12-31$36.31M+4.1%

Compare VSTM, FHTX, ZOMDF, BHST side by side · Screen every company in Pharmaceutical Preparations ↗